## 3 Results and Discussion
### In Silico Design of a Protein against Metabolic Syndrome
\begin{table}
\begin{tabular}{c c c c c c c c c c c c c c c c} \hline \hline  & **Unipot Entry** & **Sequence Length** & **IW** & **VW** & **VY** & **IY** & **EY** & **DG** & **IPI** & **GW** & **CG** & **DW** & **DE** & **Total** & \(A\) \\ \hline
**Soy** & **\(\beta\)**-**complicinin chain alfa** & P11827 & 617 & 0 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 6 & 7 & 0.011 \\ \(\beta\)**-**complicinin chain beta** & P25974 & 426 & 0 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 0 & 2 & 3 & 0.007 \\ \(\lambda\)**lumin 25** & P19594 & 137 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 2 & 2 & 0.015 \\
**Basic 75 Globular** & P1917 & 403 & 0 & 1 & 1 & 0 & 1 & 1 & 0 & 0 & 1 & 0 & 0 & 5 & 0.012 \\
**Amarath** & **115 Globular** & Q38712 & 501 & 0 & 1 & 1 & 2 & 1 & 1 & 0 & 0 & 0 & 2 & 8 & 0.016 \\
**Oat** & **\(\beta\)**0356 & 201 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 1 & 0.005 \\
**115 Globular** & Q38780 & 503 & 0 & 0 & 2 & 2 & 1 & 1 & 0 & 0 & 0 & 0 & 2 & 8 & 0.016 \\
**Banes** & **\(\beta\)**0463 & 404 & 0 & 0 & 2 & 1 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 3 & 0.007 \\
**Globalin-1** & **\(\beta\)**0470 & 224 & 0 & 0 & 0 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 2 & 3 & 0.013 \\
**Alpha-zein 16** & P04700 & 242 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 1 & 0.004 \\
**Gamma-zein** & C07931 & 267 & 0 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 2 & 0 & 3 & 0.011 \\
**Rice** & **\(\beta\)**0463 & 131 & 0 & 1 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 0 & 2 & 0.015 \\
**Prolamini PROLINE 4E** & Q0 DJ45 & 131 & 0 & 1 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 0 & 5 & 7 & 0.016 \\
**Cupinin** & **\(\beta\)**0479 & 436 & 0 & 0 & 1 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 2 & 0.012 \\
**Clebulin** & P29835 & 164 & 0 & 0 & 0 & 0 & 1 & 0 & 0 & 1 & 0 & 0 & 0 & 2 & 0.012 \\
**Glutelin** & Q61725 & 471 & 0 & 0 & 3 & 1 & 2 & 2 & 0 & 0 & 0 & 0 & 3 & 11 & 0.023 \\
**Glutelin Type A-2** & P07730 & 475 & 0 & 0 & 3 & 1 & 0 & 1 & 0 & 0 & 0 & 0 & 3 & 8 & 0.017 \\
**Glutelin Type B-2** & Q20897 & 481 & 0 & 0 & 4 & 1 & 1 & 2 & 0 & 0 & 0 & 0 & 2 & 10 & 0.021 \\
**Maze** & **\(\beta\)**15590 & 487 & 0 & 0 & 0 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 2 & 3 & 0.006 \\
**Globalin-1** \(\beta\)**04896 & 245 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0.000 \\
**50 kDa gamma zein** & C07931 & 267 & 0 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 2 & 0 & 3 & 0.011 \\
**Globulin-2** & **\(\beta\)**07128 & 431 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 0 & 3 & 4 & 0.009 \\
**Globulin-1** & A08710 & 224 & 0 & 0 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 2 & 3 & 0.013 \\
**18 kD delta zein** & Q946V9 & 190 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0 & 0.000 \\
**Prolamini PROL 17** & **\(\beta\)**0463 & 164 & 0 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 3 & 0 & 0 & 4 & 0.024 \\
**Clebcea** & **\(\beta\)**0463 & 475 & 1 & 0 & 0 & 1 & 0 & 1 & 0 & 0 & 0 & 0 & 0 & 7 & 10 & 0.021 \\
**Globulin-1 S Allele** & A0A1527256 & 621 & 0 & 0 & 0 & 1 & 1 & 2 & 0 & 1 & 1 & 0 & 3 & 9 & 0.014 \\
**115 Globulin seed storage** & A0A1527C13 & 348 & 1 & 1 & 2 & 0 & 0 & 2 & 0 & 0 & 0 & 0 & 1 & 7 & 0.020 \\ \hline \hline \end{tabular}
\end{table} 
Table 2: Frequency of the selected bioactive peptides in vegetable proteins and their \(A\) number (relative frequency of bioactive peptides able to treat metabolic syndrome).